Estimates Revisions CellaVision AB OTC Markets
Stocks
CLVSF
SE0000683484
Advanced Medical Equipment & Technology
|
Delayed
OTC Markets
00:52:56 24/06/2026 HKT
|
5-day change | 1st Jan Change | ||
| 14.00 USD | +3.78% |
|
-.--% | -16.80% |
| 09-15 | Cellavision's newly appointed CEO Stephen Ferguson makes his first share purchase for SEK 1.3m | FW |
| 09-14 | Lannebo Hälsa och Ny Teknik rose 5.9% in August, Bico among the month's winners | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
CellaVision AB(CEVI)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
CellaVision AB(CEVI)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
CellaVision AB(CEVI)
EBIT
Dividend / Share (DPS)
Data source:
CellaVision AB(CEVI)
Cash or Net Debt
- Stock Market
- Stocks
- CEVI Stock
- CLVSF Stock
- Consensus CellaVision AB
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
